Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy.
OBJECTIVE
To prospectively compare an investigational version of a complex-based chemical shift-based fat fraction magnetic resonance (MR) imaging method with MR spectroscopy for the quantification of hepatic steatosis.


METHODS
This study was approved by the institutional review board and was HIPAA compliant. Written informed consent was obtained before all studies. Fifty-five patients (31 women, 24 men; age range, 24-71 years) were prospectively imaged at 1.5 T with quantitative MR imaging and single-voxel MR spectroscopy, each within a single breath hold. The effects of T2 correction, spectral modeling of fat, and magnitude fitting for eddy current correction on fat quantification with MR imaging were investigated by reconstructing fat fraction images from the same source data with different combinations of error correction. Single-voxel T2-corrected MR spectroscopy was used to measure fat fraction and served as the reference standard. All MR spectroscopy data were postprocessed at a separate institution by an MR physicist who was blinded to MR imaging results. Fat fractions measured with MR imaging and MR spectroscopy were compared statistically to determine the correlation (r(2)), and the slope and intercept as measures of agreement between MR imaging and MR spectroscopy fat fraction measurements, to determine whether MR imaging can help quantify fat, and examine the importance of T2 correction, spectral modeling of fat, and eddy current correction. Two-sided t tests (significance level, P = .05) were used to determine whether estimated slopes and intercepts were significantly different from 1.0 and 0.0, respectively. Sensitivity and specificity for the classification of clinically significant steatosis were evaluated.


RESULTS
Overall, there was excellent correlation between MR imaging and MR spectroscopy for all reconstruction combinations. However, agreement was only achieved when T2 correction, spectral modeling of fat, and magnitude fitting for eddy current correction were used (r(2) = 0.99; slope ± standard deviation = 1.00 ± 0.01, P = .77; intercept ± standard deviation = 0.2% ± 0.1, P = .19).


CONCLUSIONS
T1-independent chemical shift-based water-fat separation MR imaging methods can accurately quantify fat over the entire liver, by using MR spectroscopy as the reference standard, when T2 correction, spectral modeling of fat, and eddy current correction methods are used.
Liver Imaging Research Program, Department of Radiology, University of Wisconsin, 600 Highland Ave, E3/311 CSC, Madison, WI 53792-3252, USA. sreeder@wisc.edu
Sina
S
Meisamy
Catherine D G
CD
Hines
Gavin
G
Hamilton
Claude B
CB
Sirlin
Charles A
CA
McKenzie
Huanzhou
H
Yu
Jean H
JH
Brittain
Scott B
SB
Reeder
D000293:Adolescent; D000328:Adult; D000368:Aged; D005234:Fatty Liver / Q000175:diagnosis* / Q000378:metabolism*; D005260:Female; D006801:Humans; D007090:Image Interpretation, Computer-Assisted; D008279:Magnetic Resonance Imaging / Q000379:methods*; D009682:Magnetic Resonance Spectroscopy / Q000379:methods*; D008297:Male; D011446:Prospective Studies; D012680:Sensitivity and Specificity; D014280:Triglycerides / Q000378:metabolism*
D014280:Triglycerides
J Magn Reson Imaging. 2009 Nov;30(5):1215-22
19856457
Ann Med. 2005;37(5):347-56
16179270
Semin Liver Dis. 2008 Nov;28(4):380-5
18956294
Am J Gastroenterol. 2009 Apr;104(4):861-7
19293782
Magn Reson Med Sci. 2003 Apr 1;2(1):47-50
16210819
JAMA. 2006 Apr 5;295(13):1549-55
16595758
Radiology. 2009 Aug;252(2):568-76
19546430
Blood. 2005 Aug 15;106(4):1460-5
15860670
Magn Reson Imaging. 2008 Apr;26(3):347-59
18093781
Magn Reson Med. 2005 Sep;54(3):636-44
16092103
Hepatology. 2006 Apr;43(4):682-9
16502396
Am J Physiol. 1999 May;276(5):E977-89
10329993
J Magn Reson Imaging. 2009 Jul;30(1):145-52
19557733
Invest Radiol. 2008 Dec;43(12):854-60
19002057
Hepatology. 2008 May;47(5):1513-23
18393289
Am J Physiol Endocrinol Metab. 2005 Feb;288(2):E462-8
15339742
Radiology. 2010 Jan;254(1):119-28
20032146
MAGMA. 2001 May;12(2-3):141-52
11390270
Obes Surg. 2005 Apr;15(4):497-501
15946428
Diabetes. 2005 Dec;54(12):3541-6
16306373
Magn Reson Imaging. 2008 Jul;26(6):847-50
18486392
Clin Liver Dis. 2007 Feb;11(1):17-23, vii
17544969
World J Gastroenterol. 2008 Jun 14;14(22):3476-83
18567074
Magn Reson Med. 2007 Aug;58(2):354-64
17654578
J Magn Reson Imaging. 2007 Oct;26(4):1153-61
17896369
Magn Reson Med. 2008 Nov;60(5):1122-34
18956464
Hepatology. 2004 Dec;40(6):1387-95
15565570
J Hepatol. 1999 Sep;31(3):421-9
10488699
Magn Reson Med. 2008 Mar;59(3):521-7
18306404
J Magn Reson. 1997 Nov;129(1):35-43
9405214
J Magn Reson Imaging. 2009 Jun;29(6):1332-9
19472390
Gastroenterology. 1999 Jun;116(6):1413-9
10348825
Magn Reson Med. 2008 Feb;59(2):382-95
18228603
Eur Radiol. 2008 Apr;18(4):806-13
17999066
Gastroenterology. 2005 Jul;129(1):113-21
16012941
J Magn Reson Imaging. 2007 Mar;25(3):644-52
17326087
Gastroenterology. 2005 Jun;128(7):1898-906
15940625
Magn Reson Med. 2006 Apr;55(4):913-7
16506186
Magn Reson Imaging. 1994;12(3):487-95
8007779
Obesity (Silver Spring). 2009 Jan;17(1):25-9
18948971
Magn Reson Med. 2005 Oct;54(4):1032-9
16142718
J Pediatr Gastroenterol Nutr. 2000 Jan;30(1):48-53
10630439
Semin Liver Dis. 2007 Aug;27(3):312-8
17682977
Gastroenterology. 1998 Feb;114(2):311-8
9453491
Radiology. 2009 Apr;251(1):67-76
19221054